Tango Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tango Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q1 2024.
  • Tango Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $625K, a 7.57% increase year-over-year.
  • Tango Therapeutics, Inc. annual Depreciation for 2023 was $2.42M, a 50.2% increase from 2022.
  • Tango Therapeutics, Inc. annual Depreciation for 2022 was $1.61M, a 79.3% increase from 2021.
  • Tango Therapeutics, Inc. annual Depreciation for 2021 was $897K, a 24.9% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $625K +$44K +7.57% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $581K +$272K +88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $309K +$105K +51.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q1 2021 $204K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.